Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
April 10, 8:09 AM
Gainers IN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday’s pre-market session. The market value of their…

ADIL

Read More
3 minute read
  • Biotech
  • General
  • News

Cocrystal Pharma Provides An Update On The Clinical Development Of Its Novel, Broad-Spectrum Antiviral Investigational Candidates

By Benzinga Newsdesk
January 4, 9:13 AM
Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") provides an update on the clinical development of its oral first-in-class pan-norovirus and pan-coronavirus dual protease inhibitor CDI-988 and its oral

COCP

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights
November 16, 5:31 PM
Gainers Aclarion (NASDAQ:ACON) stock moved upwards by 33.1% to $0.45 during Thursday’s after-market session. Trading volume for this…

ACON

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
November 15, 5:31 PM
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday’s after-market session. Today’s trading volume…

AUGX

Read More
2 minute read
  • Biotech
  • General
  • News

Cocrystal Pharma Receives UK MHRA Authorization To Initiate Its Phase 2a Influenza Human Challenge Trial With Oral PB2 Inhibitor CC-42344

By Benzinga Newsdesk
October 31, 8:04 AM
Cocrystal Pharma, Inc. (NASDAQ:COCP) (Cocrystal or the Company) announces receipt of authorization from the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) to initiate a Phase 2a human challenge

COCP

Read More
2 minute read
  • Analyst Ratings

Analyst Ratings for Cocrystal Pharma

By Benzinga Insights
August 15, 3:00 PM
Cocrystal Pharma (NASDAQ:COCP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

COCP

Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

Cocrystal Pharma Presents New Data From Its CC-42344 Phase 1 Influenza A Study At The 7th Annual ISIRV Antiviral Group Conference

By Happy Mohamed
May 4, 5:05 PM
Cocrystal Pharma, Inc. (NASDAQ:COCP) (Cocrystal or the Company) announces that new data from its CC-42344 Phase 1 influenza A Study was presented today by Sam Lee, Ph.D., President and co-CEO, at the 7th Annual

COCP

Read More
2 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News

Cocrystal Pharma To Present New Data From Its CC-42344 Phase 1 Influenza A Study At The 7th Annual ISIRV Antiviral Group Conference

By Happy Mohamed
April 18, 8:38 AM
Cocrystal Pharma, Inc. (NASDAQ:COCP) (Cocrystal or the Company) announces the acceptance of an oral presentation containing new data from the Company's CC-42344 Phase 1 influenza A study at the 7th Annual

COCP

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Why Cocrystal Pharma Shares Are Trading Higher Today

By Sean Torres
April 10, 2:43 PM
Cocrystal Pharma (NASDAQ: COCP) shares are trading higher after the company completed a $4 million private placement.

COCP

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin
April 10, 12:42 PM
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.

AMBO

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service